Neurology

Autonomic

1 case on postural orthostatic tachycardia syndrome (POTS) agent selection with no clear first-line consensus — choose the case below to open its full multi-voice debate.

NeurologyAutonomic

Postural Orthostatic Tachycardia Syndrome: Selecting a First Agent Without Guideline Consensus

A single patient, five months past a mild COVID-19 infection, with a confirmed hyperadrenergic phenotype and normal orthostatic blood pressure. Four drugs are commonly reached for in this diagnosis. None carries a strong guideline recommendation, and the drug with the newest, most population-matched trial evidence isn’t the one the standing consensus statement actually names.

Case 0001→

← Back to Neurology IV